243.35
Overview
News
Price History
Option Chain
Financials
Why WST Down?
Discussions
Forecast
Stock Split
Dividend History
West Pharmaceutical Services Inc stock is traded at $243.35, with a volume of 823.52K.
It is down -1.92% in the last 24 hours and down -4.32% over the past month.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
See More
Previous Close:
$248.12
Open:
$247.44
24h Volume:
823.52K
Relative Volume:
0.88
Market Cap:
$17.54B
Revenue:
$3.07B
Net Income/Loss:
$493.70M
P/E Ratio:
35.82
EPS:
6.7935
Net Cash Flow:
$468.90M
1W Performance:
+2.67%
1M Performance:
-4.32%
6M Performance:
-6.95%
1Y Performance:
+7.65%
West Pharmaceutical Services Inc Stock (WST) Company Profile
Name
West Pharmaceutical Services Inc
Sector
Industry
Phone
(610) 594-2900
Address
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
WST
West Pharmaceutical Services Inc
|
243.35 | 17.54B | 3.07B | 493.70M | 468.90M | 6.7935 |
|
ISRG
Intuitive Surgical Inc
|
452.66 | 160.77B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
154.51 | 43.95B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
73.34 | 35.75B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
41.36 | 33.57B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
220.47 | 32.12B | 5.40B | 1.49B | 1.78B | 10.12 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-25 | Initiated | Rothschild & Co Redburn | Buy |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Mar-18-25 | Initiated | Evercore ISI | Outperform |
| Feb-14-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-08-25 | Initiated | Citigroup | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-12-24 | Upgrade | UBS | Neutral → Buy |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-11-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Nov-30-22 | Initiated | UBS | Neutral |
| Oct-28-22 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-14-20 | Initiated | Stephens | Equal-Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-24-20 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Dec-12-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| May-01-19 | Downgrade | Jefferies | Buy → Hold |
| Apr-23-19 | Initiated | William Blair | Outperform |
| Apr-25-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-24-18 | Initiated | Goldman | Neutral |
| Oct-17-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-03-17 | Initiated | Stephens | Equal-Weight |
| Sep-15-17 | Upgrade | Jefferies | Hold → Buy |
| Oct-28-16 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Sep-21-16 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Mar-22-16 | Initiated | Wells Fargo | Outperform |
| May-14-10 | Reiterated | UBS | Neutral |
| Feb-23-10 | Initiated | Jefferies & Co | Buy |
| Dec-19-08 | Initiated | UBS | Neutral |
View All
West Pharmaceutical Services Inc Stock (WST) Latest News
Upcoming drug delivery talk sees West Pharmaceutical Services stock fall 1.92% amid weak technical signals - tradersunion.com
West Pharmaceutical CEO plans exit after 11 years, succession process underway - MSN
Nordea Investment Management AB Increases Position in West Pharmaceutical Services, Inc. $WST - marketbeat.com
WST (West Pharmaceutical Services) Predictability Rank - GuruFocus
Q2 2024 West Pharmaceutical Services Inc Earnings Call Transcript - GuruFocus
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
Vanguard (NYSE: WST) reports 0% stake after January 12, 2026 realignment - Stock Titan
Stock List: Research Stocks from Around the World - GuruFocus
West Pharmaceutical Services Inc (WST)'s Winning Formula: Financ - GuruFocus
Riverbridge Partners LLC Has $87.66 Million Stake in West Pharmaceutical Services, Inc. $WST - marketbeat.com
SG Americas Securities LLC Boosts Stake in West Pharmaceutical Services, Inc. $WST - marketbeat.com
Is West Pharmaceutical Services, Inc. (WST) A Good Stock To Buy Now? - uk.finance.yahoo.com
West Pharmaceutical CEO Plans Exit after 11 Years, Succession Process Underway - Insider Monkey
West Pharmaceutical Services to present FluroTec Barrier Film benefits at ChemPharma Summit - tradersunion.com
Buyback Watch: Is West Pharmaceutical Services Inc stock showing strong momentumMarket Performance Recap & Scalable Portfolio Growth Ideas - baoquankhu1.vn
West Pharma declares dividend as Exton giant signals steady footing - MSN
Assenagon Asset Management S.A. Has $69.06 Million Stake in West Pharmaceutical Services, Inc. $WST - marketbeat.com
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical declares $0.22 dividend - MSN
Pharmaceutical Packaging and cGMP: Trusted Companies Setting New Standards - Medical Device Network
West Pharmaceutical Services, Inc. $WST is Seilern Investment Management Ltd's 7th Largest Position - marketbeat.com
West CEO Eric Green plans retirement pending successor search - MSN
Exton-based West Pharmaceutical reports higher Q4 sales, earnings - MSN
WST launches Synchrony S1 prefillable syringe at Pharmapack - msn.com
Here is why West Pharmaceutical Services, Inc. (WST) is strongly favored by hedge funds - MSN
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
West Pharmaceutical Services Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Here's Why You Should Add McKesson Stock to Your Portfolio Now - TradingView
West Pharmaceutical Services, Inc. $WST Shares Purchased by JPMorgan Chase & Co. - marketbeat.com
3 Overvalued Stocks: High P/E Ratios Signal Risk Amid Slowing GrowthNews and Statistics - IndexBox
West Pharmaceutical Services expert to present medical device biocompatibility strategy at key summit - Traders Union
Pharmaceutical Packaging Market: Serialization & Track-and-Trace Compliance, Global Regulatory Mandates, & Industry Growth Outlook - vocal.media
West Pharmaceutical Stock (ISIN: US9523901012) Faces Pressure Amid Pharma Supply Chain Shifts and Ea - AD HOC NEWS
West Pharmaceutical Services at KeyBanc Forum: Strategic Growth Insights By Investing.com - Investing.com Canada
West CEO Eric Green Plans Retirement Pending Successor Search - MyChesCo
West Pharmaceutical declares dividend, authorizes $1B buyback - MSN
West Pharmaceutical Services showcases device innovation at COPHEX Korea event - Traders Union
Moore Capital Management LP Purchases New Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Holocene Advisors LP Takes $49.09 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Improved Investor Confidence Boosted West Pharmaceutical Services (WST) - MSN
West Pharmaceutical Services urges industry to adapt as USP draft chapters reshape contamination control - Traders Union
The Zacks Analyst Blog Highlights Atmos Energy, Colgate-Palmolive and West Pharmaceutical Services - The Globe and Mail
Iron Triangle Partners LP Purchases New Stake in West Pharmaceutical Services, Inc. $WST - MarketBeat
Hillman Capital Management Inc. Takes $2.70 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Will CEO Succession and Chair Role Debate Reshape West Pharmaceutical’s Governance Story (WST)? - Yahoo Finance
Cinctive Capital Management LP Makes New $3.76 Million Investment in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical CEO Eric Green to retire in second half 2026 - Investing.com Nigeria
How Leadership Transition And Governance Debate At West Pharmaceutical (WST) Has Changed Its Investment Story - simplywall.st
West Pharmaceutical Services, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Bamco Inc. NY Sells 6,716 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. $WST Stake Lifted by Ossiam - MarketBeat
West Pharmaceutical Services Inc Stock (WST) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):